Sotera Health Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Michael Petras

Geschäftsführender

US$9.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts10.8%
Amtszeit als Geschäftsführer8yrs
Eigentum des Geschäftsführers2.0%
Durchschnittliche Amtszeit des Managements3.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3.7yrs

Jüngste Management Updates

Recent updates

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug 04

Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

May 09
Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Mar 16
Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Jan 19
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Michael Petras im Vergleich zu den Einnahmen von Sotera Health verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

US$55m

Dec 31 2023US$10mUS$1m

US$51m

Sep 30 2023n/an/a

-US$306m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$261m

Dec 31 2022US$17mUS$1m

-US$234m

Sep 30 2022n/an/a

US$121m

Jun 30 2022n/an/a

US$123m

Mar 31 2022n/an/a

US$135m

Dec 31 2021US$2mUS$1m

US$115m

Sep 30 2021n/an/a

US$36m

Jun 30 2021n/an/a

US$9m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$17mUS$728k

-US$39m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$2mUS$700k

-US$21m

Vergütung im Vergleich zum Markt: MichaelDie Gesamtvergütung ($USD9.70M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD6.80M).

Entschädigung vs. Einkommen: MichaelDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Michael Petras (55 yo)

8yrs

Amtszeit

US$9,701,005

Vergütung

Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 67.4m
Jonathan Lyons
Senior VP & CFOless than a yearUS$2.18mkeine Daten
Alexander Dimitrief
Senior VP1.6yrsUS$862.18k0.083%
$ 2.8m
Michael Rutz
President of Sterigenics3.7yrsUS$2.03m0.17%
$ 5.7m
Robert Hauzie
Chief Information Officer5.4yrskeine Datenkeine Daten
Kristin Gibbs
Chief Marketing Officer7.6yrskeine Datenkeine Daten
William Lehmann
Senior Vice President of Strategy & Corporate Development2.4yrskeine Datenkeine Daten
Sally Turner
Chief Human Resources Officer5.4yrskeine Datenkeine Daten
Kathleen Hoffman
Senior Vice President of Global Environmentalno datakeine Datenkeine Daten
Joseph Shrawder
President of Nelson Labs3.7yrskeine Datenkeine Daten
Riaz Bandali
President of Nordion2.3yrskeine Datenkeine Daten
Jason Peterson
VP & Treasurerno datakeine Datenkeine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

54.5yo

Durchschnittliches Alter

Erfahrenes Management: SHCDas Führungsteam des Unternehmens gilt als erfahren (3.7 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 67.4m
David Donnini
Independent Director3.7yrsUS$302.50k0.015%
$ 499.1k
James Neary
Independent Director3.7yrsUS$320.00k0.015%
$ 499.1k
Constantine Mihas
Independent Director3.7yrsUS$305.00k0.015%
$ 499.1k
Sean Cunningham
Independent Director3.7yrsUS$302.50k0.015%
$ 499.1k
Vincent Petrella
Independent Director3.6yrsUS$325.00k0.015%
$ 499.1k
Ann Klee
Independent Director3.7yrsUS$322.50k0.031%
$ 1.0m
Robert Knauss
Independent Director1.7yrsUS$300.00k0.0056%
$ 188.7k
Ruoxi Chen
Independent Director3.6yrsUS$302.50k0.015%
$ 499.1k
David Wheadon
Independent Director3.1yrsUS$310.00k0.013%
$ 428.7k
Karen Flynn
Independent Directorless than a yearUS$9.99kkeine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: SHCDie Vorstandsmitglieder gelten als erfahren (3.7 Jahre durchschnittliche Amtszeit).